Thrombosis risk stratification: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
No edit summary
WikiBot (talk | contribs)
No edit summary
Line 18: Line 18:
*'''Medical'''
*'''Medical'''
**Surgery
**Surgery
**[[Congestive heart failure and thrombosis|Heart failure]]
**[[Trauma]]
**[[Trauma]]
**[[Oral contraceptive]] use
**[[Oral contraceptive]] use

Revision as of 18:44, 28 September 2011

Thrombosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Classification

Arterial
Venous
Arterial and Venous Thrombosis: Differences and Similarities

Causes

Site of Thrombosis

Arterial
Venous

Differentiating Thrombosis from other Diseases

Arterial
Venous

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Evaluation

Treatment

Risk Factor Modifications

Prevention

Thrombosis risk stratification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombosis risk stratification

CDC onThrombosis risk stratification

Thrombosis risk stratification in the news

Blogs on Thrombosis risk stratification

to Hospitals Treating Thrombosis risk stratification

Risk calculators and risk factors for Thrombosis risk stratification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]

Overview

Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor.

Risk factors

Template:SIB

cs:Trombóza de:Thrombose eo:Trombozo it:Trombosi he:תרומבוס ms:Trombotik nl:Trombose fi:Verihiutale

Template:WH Template:WS